Lori Lowe

7.9k total citations
154 papers, 5.2k citations indexed

About

Lori Lowe is a scholar working on Oncology, Epidemiology and Dermatology. According to data from OpenAlex, Lori Lowe has authored 154 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Oncology, 53 papers in Epidemiology and 50 papers in Dermatology. Recurrent topics in Lori Lowe's work include Cutaneous Melanoma Detection and Management (47 papers), Nonmelanoma Skin Cancer Studies (30 papers) and Cancer and Skin Lesions (21 papers). Lori Lowe is often cited by papers focused on Cutaneous Melanoma Detection and Management (47 papers), Nonmelanoma Skin Cancer Studies (30 papers) and Cancer and Skin Lesions (21 papers). Lori Lowe collaborates with scholars based in United States, Canada and France. Lori Lowe's co-authors include Timothy M. Johnson, Vernon K. Sondak, Douglas R. Fullen, Carol R. Bradford, Lyndon D. Su, Alfred E. Chang, Sandra L. Wong, Vincent M. Cimmino, Michael S. Sabel and Jennifer Schwartz and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Cancer.

In The Last Decade

Lori Lowe

146 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori Lowe United States 45 3.4k 1.7k 1.3k 949 572 154 5.2k
Marie‐Françoise Avril France 45 3.6k 1.1× 1.1k 0.6× 953 0.7× 2.0k 2.1× 1.5k 2.6× 161 6.2k
Mary S. Brady United States 37 3.5k 1.0× 1.0k 0.6× 618 0.5× 997 1.1× 603 1.1× 106 4.7k
C. Wayne Cruse United States 35 3.2k 1.0× 1.8k 1.0× 779 0.6× 692 0.7× 411 0.7× 105 4.3k
María Teresa Fernández‐Figueras Spain 35 1.4k 0.4× 1.0k 0.6× 1.1k 0.9× 896 0.9× 830 1.5× 198 4.4k
Jonathan S. Zager United States 46 4.4k 1.3× 1.2k 0.7× 403 0.3× 1.9k 2.0× 1.2k 2.2× 288 6.3k
Phillip H. McKee United Kingdom 44 2.0k 0.6× 1.3k 0.8× 2.0k 1.5× 714 0.8× 230 0.4× 127 5.4k
Zsolt B. Argényi United States 30 1.4k 0.4× 814 0.5× 983 0.7× 485 0.5× 206 0.4× 104 3.0k
Bita Esmaeli United States 46 3.7k 1.1× 1.9k 1.1× 1.5k 1.1× 1.0k 1.1× 613 1.1× 271 8.1k
John A. Zitelli United States 42 2.3k 0.7× 2.6k 1.5× 1.8k 1.3× 395 0.4× 139 0.2× 123 4.9k
Michael Veness Australia 39 3.2k 0.9× 2.4k 1.4× 1.5k 1.1× 224 0.2× 88 0.2× 133 4.6k

Countries citing papers authored by Lori Lowe

Since Specialization
Citations

This map shows the geographic impact of Lori Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Lowe more than expected).

Fields of papers citing papers by Lori Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Lowe. The network helps show where Lori Lowe may publish in the future.

Co-authorship network of co-authors of Lori Lowe

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Lowe. A scholar is included among the top collaborators of Lori Lowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Lowe. Lori Lowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durgin, Joseph S., Douglas R. Fullen, Alexandra C. Hristov, et al.. (2025). Role of single‐nucleotide polymorphism microarray in the classification of BAP1‐inactivated melanocytic tumours. Histopathology. 87(1). 110–129. 1 indexed citations
2.
Klein, Benjamin, Paul H. O’Brien, Lin Zhang, et al.. (2025). Epidermal Interferon‐κ Drives Cutaneous Lupus‐Like Lesions, Photosensitivity, and Systemic Autoimmunity In Vivo. Arthritis & Rheumatology. 78(1). 184–197. 1 indexed citations
3.
Ross, Charles W., et al.. (2023). Myelodysplasia Cutis. Archives of Pathology & Laboratory Medicine. 148(4). 385–389. 3 indexed citations
4.
Hile, Grace A., Noah A. Brown, Douglas R. Fullen, et al.. (2021). Immunophenotypic switch in cutaneous T‐cell lymphoma: A series of three cases and review of the literature. Journal of Cutaneous Pathology. 48(7). 986–994. 6 indexed citations
5.
Al‐Omari, Ahmed, Michael D. Carter, Paul W. Harms, et al.. (2020). DNA copy number changes correlate with clinical behavior in melanocytic neoplasms: proposal of an algorithmic approach. Modern Pathology. 33(7). 1307–1317. 21 indexed citations
6.
Berthier, Céline C., Lam C. Tsoi, Tamra J. Reed, et al.. (2019). Molecular Profiling of Cutaneous Lupus Lesions Identifies Subgroups Distinct from Clinical Phenotypes. Journal of Clinical Medicine. 8(8). 1244–1244. 51 indexed citations
7.
Vidal, Claudia I., M. Yadira Hurley, Murad Alam, et al.. (2019). Muir‐Torre syndrome appropriate use criteria: Effect of patient age on appropriate use scores. Journal of Cutaneous Pathology. 46(7). 484–489. 9 indexed citations
9.
Smith, Emily H., et al.. (2017). Extranodal natural killer/T-cell lymphoma, nasal type: A rare but critical diagnosis. JAAD Case Reports. 3(3). 225–227. 5 indexed citations
10.
Udager, Aaron M., Linda Hong, Marina Stasenko, et al.. (2017). Gynecologic melanomas: A clinicopathologic and molecular analysis. Gynecologic Oncology. 147(2). 351–357. 26 indexed citations
11.
Reed, Tamra J., et al.. (2015). Epidermal injury promotes nephritis flare in lupus-prone mice. Journal of Autoimmunity. 65. 38–48. 23 indexed citations
12.
Schwartz, Jennifer, Kent A. Griffith, Lori Lowe, et al.. (2011). Features Predicting Sentinel Lymph Node Positivity in Merkel Cell Carcinoma. Journal of Clinical Oncology. 29(8). 1036–1041. 114 indexed citations
13.
Zheng, Huarui, Neha U. Patel, Jiong Yang, et al.. (2008). Induction of abnormal proliferation by non-myelinating Schwann cells triggers neurofibroma formation. Cancer Research. 68. 2955–2955. 3 indexed citations
14.
Arora, Alisha, Lori Lowe, Lyndon Su, et al.. (2005). Wide excision without radiation for desmoplastic melanoma. Cancer. 104(7). 1462–1467. 36 indexed citations
15.
Pacella, Salvatore J., Lori Lowe, Carol R. Bradford, et al.. (2003). The Utility of Sentinel Lymph Node Biopsy in Head and Neck Melanoma in the Pediatric Population. Plastic & Reconstructive Surgery. 112(5). 1257–1265. 32 indexed citations
16.
Su, Lyndon D., Douglas R. Fullen, Lori Lowe, et al.. (2002). CD117 (KIT Receptor) Expression in Merkel Cell Carcinoma. American Journal of Dermatopathology. 24(4). 289–293. 89 indexed citations
17.
Anderson, Kenneth W., Shan R. Baker, Lori Lowe, Lyndon Su, & Timothy M. Johnson. (2001). Treatment of Head and Neck Melanoma, Lentigo Maligna Subtype. Archives of Facial Plastic Surgery. 3(3). 202–206. 57 indexed citations
18.
Sondak, Vernon K., Vincent M. Cimmino, Lori Lowe, Derek A. DuBay, & Timothy M. Johnson. (1999). Dermatofibrosarcoma protuberans: what is the best surgical approach?. Surgical Oncology. 8(4). 183–189. 27 indexed citations
19.
Lowe, Lori, et al.. (1998). Basal cell carcinoma arising in a sternotomy scar: A report of three cases. Journal of the American Academy of Dermatology. 38(3). 491–493. 13 indexed citations
20.
Johnson, Timothy M., et al.. (1994). Unusual basal cell carcinomas.. PubMed. 54(2). 85–92. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026